E11(R1) Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 11, 2018
April 11, 2024
e3307e6f-23c2-45a6-9825-5ae810b26dda
Related Documents
Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics: Guidance for Industry
Guidance DocumentDecember 19, 2018Center for Drug Evaluation and Research
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry
Guidance DocumentJuly 19, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.